Suppr超能文献

川崎病患者冠状动脉瘤风险高。

High risk of coronary artery aneurysm in Kawasaki disease.

机构信息

Section of Pediatrics, Pediatrics, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden.

Section of Rheumatology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden.

出版信息

Rheumatology (Oxford). 2021 Apr 6;60(4):1910-1914. doi: 10.1093/rheumatology/keaa512.

Abstract

OBJECTIVE

Kawasaki disease (KD) is a vasculitis of unknown aetiology with a high risk of coronary aneurysms if untreated. Timely treatment with intravenous immunoglobulin decreases the risk for coronary artery aneurysms (CAA). In this study, we set out to elucidate the factors associated with the risk of developing CAA.

METHODS

Records of all KD-diagnosed children in Skåne between 2004 and 2014 were collected and clinical and demographic data were compiled. KD is defined according to the revised American Heart Association diagnostic criteria and classified as either complete KD (cKD) or incomplete KD (iKD).

RESULTS

KD was diagnosed in 77 children and CAA was found in 31% (n = 24). Children with CAA were younger compared with children without (median; 20 vs 34 months) and intravenous immunoglobulin treatment within 10 days was less likely to be received (75% vs 91%). In children presenting with iKD, 47% developed CAA compared with 21% in cKD patients. Using multivariate analysis, an association between the risk of CAA with low age in children with iKD was observed.

CONCLUSION

The risk of CAA development is disturbingly high in young children with iKD. This highlights the importance of rapid intense treatment and vigilance in infants, who are the most difficult to diagnose, in order to reduce the frequency of CAA.

摘要

目的

川崎病(KD)是一种病因不明的血管炎,如果不治疗,有发生冠状动脉瘤的高风险。及时静脉注射免疫球蛋白治疗可降低冠状动脉瘤(CAA)的风险。本研究旨在阐明与发生 CAA 风险相关的因素。

方法

收集了 2004 年至 2014 年在斯科讷地区所有确诊为 KD 的儿童的记录,并汇编了临床和人口统计学数据。KD 根据修订后的美国心脏协会诊断标准定义,并分为完全川崎病(cKD)或不完全川崎病(iKD)。

结果

共诊断出 77 例 KD,其中 31%(n=24)发现 CAA。与无 CAA 的儿童相比,有 CAA 的儿童年龄更小(中位数;20 个月比 34 个月),且更不可能在 10 天内接受静脉免疫球蛋白治疗(75%比 91%)。在表现为 iKD 的儿童中,47%发生了 CAA,而 cKD 患者中为 21%。多变量分析显示,iKD 患儿中 CAA 发病风险与年龄低之间存在关联。

结论

iKD 患儿中 CAA 发生的风险高得令人不安。这突出表明,对于最难以诊断的婴儿,需要迅速进行强化治疗并保持警惕,以降低 CAA 的发生频率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b00/8023999/61e4dd1c96d6/keaa512f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验